The Perfect Predator: A Scientist's Race to Save Her Husband from a Deadly Superbug: A Memoir

by Steffanie Strathdee

New clinical trials of phage therapy are now underway for patients battling superbug infections associated with cystic fibrosis and implanted medical devices.

The US National Institute of Health funded their first phage therapy trial in 2019 which will be co-led by Chip Schooley at IPATH and 19 other sites. COVID delayed its start date but the first patient was enrolled in July, 2022.